These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3250823)

  • 41. [Radiotherapy of esophageal carcinoma].
    Scherer E
    Dtsch Med Wochenschr; 1979 Sep; 104(37):1296. PubMed ID: 477548
    [No Abstract]   [Full Text] [Related]  

  • 42. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
    Zhao KL; Shi XH; Jiang GL; Yao WQ; Guo XM; Wu GD; Zhu LX
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1014-20. PubMed ID: 15990003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Combined radiotherapy of esophageal cancer].
    Fel'dman SZ; Musapirova NA; Mamekova GK; Zevrieva IF; Balmukhanov SB
    Med Radiol (Mosk); 1988 Jan; 33(1):36-40. PubMed ID: 3339976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Downstaging of esophageal carcinoma after preoperative radio- and chemotherapy].
    Staar S
    Strahlenther Onkol; 1996 Dec; 172(12):693-5. PubMed ID: 8992641
    [No Abstract]   [Full Text] [Related]  

  • 45. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma.
    Gao XS; Qiao XY; Yang XR; Asaumi J; Zhou ZG; Wang YD; Zhou DA; Wan J; Kuroda M; Kishi K; Kawasaki S; Hiraki Y
    Oncol Rep; 2002; 9(4):767-72. PubMed ID: 12066206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
    Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ;
    Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma.
    Qiao XY; Wang W; Zhou ZG; Gao XS; Chang JY
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):396-402. PubMed ID: 17855004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The quality of swallowing for patients with operable esophageal carcinoma: a randomized trial comparing surgery with radiotherapy.
    Badwe RA; Sharma V; Bhansali MS; Dinshaw KA; Patil PK; Dalvi N; Rayabhattanavar SG; Desai PB
    Cancer; 1999 Feb; 85(4):763-8. PubMed ID: 10091752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The present place of radiation therapy in the management of esophageal cancer.
    Pearson JG
    Prog Clin Cancer; 1970; 4():257-71. PubMed ID: 4984641
    [No Abstract]   [Full Text] [Related]  

  • 51. Chemoradiation as primary management of esophageal cancer.
    Coia LR
    Semin Oncol; 1994 Aug; 21(4):483-92. PubMed ID: 8042046
    [No Abstract]   [Full Text] [Related]  

  • 52. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy.
    Fang FM; Tsai WL; Chiu HC; Kuo WR; Hsiung CY
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1394-404. PubMed ID: 15050315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Esophageal carcinoma. Results of telecobalttherapy in comparison with conventional x-ray depth therapy].
    Eichhorn HJ; Rotte KH
    Med Klin; 1966 Apr; 61(14):539-42. PubMed ID: 5987558
    [No Abstract]   [Full Text] [Related]  

  • 54. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
    Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
    Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
    Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Index of the lesion as a quantitative criterion for radiation pathomorphosis].
    Lavnikova GA
    Med Radiol (Mosk); 1979 Dec; 24(12):14-8. PubMed ID: 513991
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of treatment with respect to radiotherapy: carcinoma of the oesophagus.
    Shehata WM
    IMJ Ill Med J; 1979 Apr; 155(4):215-7. PubMed ID: 35491
    [No Abstract]   [Full Text] [Related]  

  • 58. [Radical radiotherapy for esophageal cancer].
    Nishio M
    Nihon Rinsho; 2011 Aug; 69 Suppl 6():348-53. PubMed ID: 22471042
    [No Abstract]   [Full Text] [Related]  

  • 59. [Radiographic evaluation of radiotherapy for esophageal neoplasms (2)].
    Imajo Y; Kimura S; Ogawa Y; Imanaka K; Oshitani T; Gose K; Ichiyanagi A; Ashida C; Hishikawa Y; Shimada T
    Rinsho Hoshasen; 1982 Sep; 27(10 Suppl):1137-42. PubMed ID: 7154298
    [No Abstract]   [Full Text] [Related]  

  • 60. [Computer-controlled conformation radiotherapy (author's transl)].
    Matsuda T; Inamura K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1979 Oct; 39(10):1088-97. PubMed ID: 523302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.